(Q73011661)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives-eleutherin, alpha lapachone, and beta lapachone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

P Krishnan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K F Bastow

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

1367-1379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

Structure and mechanism of DNA topoisomerase II

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

DNA topoisomerase poisons as antitumor drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Catalytic inhibitors of DNA topoisomerase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Elecanacin, a Novel New Naphthoquinone from the Bulb of Eleutherine americana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Effects of beta-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosoma cruzi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Bioactivation as a model for drug design bioreductive alkylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Redox cycling of beta-lapachone and related o-naphthoquinones in the presence of dihydrolipoamide and oxygen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro-1,3-dihydroxyacridone and 1,3,7-trihydroxyacridone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Biochemical basis for the interactions of type I and type II topoisomerases with DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Mechanism of topoisomerase II inhibition by staurosporine and other protein kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Intradimerically tethered DNA topoisomerase II is catalytically active in DNA transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900437-8

10.1016/S0006-2952(00)00437-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008131%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference